Global Pharmaceutical Research & Development, Abbvie, Inc., North Chicago, IL, USA.
Future Med Chem. 2018 Apr 1;10(8):837-838. doi: 10.4155/fmc-2018-0002. Epub 2018 Mar 27.
Stevan Djuric speaks to Benjamin Walden, Commissioning Editor. Stevan Djuric is head of the global Medicinal Chemistry Leadership Team at AbbVie and is also Vice President of the Discovery Chemistry and Technology organization within their Discovery organization and chemistry outsourcing activities. He spoke at the Global-Medicinal-Chemistry and GPCR summit on the imperative to develop chemistry related technology that can reduce cycle time, cost of goods and improve probability of success. To this end, he discussed his efforts in the chemistry technology area with a focus on integrated synthesis-purification bioassay, and flow photochemistry and high temperature chemistry platforms.
斯特凡·朱里奇接受了本杰明·沃尔登的采访，本杰明·沃尔登是 commissioning editor。斯特凡·朱里奇是 AbbVie 全球药物化学领导团队的负责人，也是其发现组织内的发现化学和技术组织以及化学外包活动的副总裁。他在全球药物化学和 GPCR 峰会上发表讲话，强调必须开发能够缩短周期时间、降低成本并提高成功率的相关化学技术。为此，他讨论了自己在化学技术领域的努力，重点是集成合成-纯化生物测定、流动光化学和高温化学平台。
